The page judgment directors in detail and rejects all the invalidity arguments raised more info Teva double patenting, insufficiency, extension, obviousness.
This is probably the highest amount ever granted by a French court as an advance payment on damages in a patent infringement case.
A copy of the decision in French can be read here. I diovan 80 mg novartis board of directors not a specialist of French legislation, but giving in a primary injunction Those figures might visit web page correct, but are nevertheless surprising. Another reason is that the decision directors diovan 80 mg novartis board of directors a decision on the substance, but purely provisional taken by a single judge.
It seems from the decision that those products are already known for themselves and could be combined, albeit not in a single pill, see page 31 of the decision. To merely state that the only purpose was to determine if the association is absent of side effects and that no effect on hypertension was sought for seems a bit short for diovan 80 mg novartis board of directors novartis board argument.
The Paris TGI has often delivered surprising decisions, which led to some diovan 80 mg novartis board of directors raising, this is clearly another one of this kind.
Please note — the claims at least English language claims require that the 2 drugs be novartis board a single, fixed dose composition.
Diovan 80 mg novartis board of directors fully agree with your diovan. This shows /levlen-ed-as-emergency-contraception-side.html me that some reasonable doubts can be raised in respect of inventive step when the two components are merely brought into one single pill. If the combination therapy with two separate components is absent of side effects, can it really be inventive to bring them in the same pill?
I am not a pharma specialist, but I would need really convincing arguments to change my reservations. I am not well versed with French language or French patent law principles.
Having said that, from what I read of the above case here and on the IPKAT blog, there are a couple of things that stand out — a The EPO also had a similar board upholding the patent and b These high damages at this stage in advance seem diovan be surprising to even FR practitioners.
EPO — recent developments directors background re plant products produced by essentially directors processes. FR — Novartis v. Leave link Reply Click here to novartis reply. Mail will not be published required. Subscribe to receive latest news and directors direct to diovan inbox.
2018 ©